Loomis Sayles & CO L P Amphastar Pharmaceuticals, Inc. Transaction History

Loomis Sayles & CO L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $18,503 - $22,454	-978 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$17.72 - $22.51 $14,335 - $18,210	-809 Reduced 45.27%	978 $19,000
Q3 2018 Nov 13, 2018	BUY	$15.39 - $19.38 $3,585 - $4,515	233 Added 14.99%	1,787 $34,000
Q2 2018 Aug 14, 2018	SELL	$14.63 - $19.6 $4,593 - $6,154	-314 Reduced 16.81%	1,554 $24,000
Q1 2018 May 11, 2018	BUY	$17.23 - $20.35 $1,671 - $1,973	97 Added 5.48%	1,868 $35,000
Q4 2017 Feb 14, 2018	SELL	$17.76 - $19.75 $497 - $553	-28 Reduced 1.56%	1,771 $34,000
Q3 2017 Nov 14, 2017	BUY	$14.73 - $17.99 $4,198 - $5,127	285 Added 18.82%	1,799 $32,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,514	1,514 $27,000

280

36.7M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.64B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.